Health: EpiPen maker accused of overcharging for asthma drug

Mylan lawsuit. A lawsuit filed Thursday by the Self-Insured Schools of California accuses EpiPen manufacturer Mylan and Sun Pharmaceutical Industries of conspiring to charge higher prices for a generic asthma medication, Axios reported, the second time this year the company has been accused of price gouging. In April, Mylan (NASDAQ-MYL) was named in a class-action racketeering lawsuit that alleged the skyrocketing price of the EpiPen, used by patients to mitigate severe allergic reactions, was the…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news